Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 September 2018 Photo Charl Devenish
Science Its a girl thing
Innocensia Mangoato’s research on using cannabis to reverse anticancer drug resistance has been awarded in the prestigious Women in Science Awards.


“There’s this misconception among young people that science is difficult and that it’s somehow a man’s domain,” says Innocensia Mangoato, Masters student in Pharmacology, who has just been awarded in the prestigious Women in Science Awards by the Department of Science and Technology.

Cannabis research

Innocensia won in the Master’s Degree category for her research on the use of cannabis in reversing anticancer drug resistance. Her department had to apply for a special permit to grow cannabis for research and medicinal purposes.

“Her findings have already indicated a promising reversal of resistance to drugs in a variety of cancers. We plan to explore these results further in a possible PhD,” says her study leader, Prof Motlalepula Matsabisa.

Innocensia says she’s always had an interest in science, and initially wanted to study medicine. She ended up doing a BSc in Physiology and Genetics.

She hopes that her research will help government to develop a policy around the use of cannabis for medicinal purposes which could ultimately lead to developing cancer treatment with fewer side-effects.

Female mentors

“My mentor during my Honours studies was Dr Makhotso Lekhoa. Her passion for her field and her patience in conveying it to others really inspired me. We have some very powerful women in our Pharmacology Department,” says Innocensia.

Passion for science 

“You know you’re passionate about your work when you find yourself going to the lab on Sunday afternoons!” she says. “I’m happy that I can be contributing to the knowledge production on this campus. And maybe one day I can be a mentor to other girls with that same passion for science.”

News Archive

UFS unveils new HPC cluster
2011-04-04

Prof. Jonathan Jansen, Prof. Theuns Verschoor and staff of the UFS ICT department at the unveiling of the HPC cluster

Our university has unveiled a brand-new multimillion-rand High Performance Computing (HPC) cluster, which promises to enhance the way research is done at our university.

The new HPC cluster is a super powerful computing cluster, and already has 28 users from six university departments using it to speed up and simplify their research. The cluster of more than R2,7 million was unveiled in March 2011.
 
It boasts an incredible 800 processing cores and special high-speed data-transfer technology, to make even the most expensive home PC look like a stone-age relic.
Prof. Janse Tolmie, Senior Director: Information and Communication Technology Services (ICT Services) at the UFS, says the cluster is used to simulate experiments and their outcome electronically, using advanced software and the high processing power of the cluster.
 
The cluster is especially useful to researchers in the Chemistry, Bio-chemistry and Medical Physics departments. Prof. Tolmie says these simulations are an internationally recognised means of conducting research and it is very important for a research institution to have access to such a facility.
 
In the past, many research articles have been published by UFS researchers, based on research done using the previous incarnation of an HPC cluster at our university.
Prof. Tolmie says the cluster can also be connected to clusters at other universities and research facilities to form national or international HPC grids.
 
This will enable researchers elsewhere to access the massive processing power that UFS researchers now have at their fingertips.
 
 
Media Release
30 March 2011
Issued by: Lacea Loader
Director: Strategic Communication
Tel: 051 401 2584
Cell: 083 645 2454
E-mail: news@ufs.ac.za

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept